CD8A and prostate carcinoma: An unfavorable prognosis has been observed in cases of prostate cancer [25], clear cell renal cell carcinoma (RCC) [26,27], Hodgkin lymphoma [28], and follicular lymphoma [29], when there is a high concentration of CD8+ T cells.